The stock of Analogic Corporation (NASDAQ:ALOG) registered a decrease of 0.16% in short interest. ALOG’s total short interest was 880,000 shares in September as published by FINRA. Its down 0.16% from 881,400 shares, reported previously. With 72,200 shares average volume, it will take short sellers 12 days to cover their ALOG’s short positions. The short interest to Analogic Corporation’s float is 7.18%. The stock decreased 1.35% or $1.21 during the last trading session, hitting $88.27. About 100,888 shares traded hands or 55.46% up from the average. Analogic Corporation (NASDAQ:ALOG) has risen 25.25% since February 8, 2016 and is uptrending. It has outperformed by 8.76% the S&P500.
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies to advance the practice of medicine and save lives. The company has a market cap of $1.11 billion. The Firm operates through three business divisions: Medical Imaging, Ultrasound, and Security and Detection. It has a 78.38 P/E ratio. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography , magnetic resonance imaging (MRI) and high-resolution digital mammography.
The institutional sentiment increased to 1.53 in 2016 Q2. Its up 0.18, from 1.35 in 2016Q1. The ratio is positive, as 13 funds sold all Analogic Corporation shares owned while 36 reduced positions. 14 funds bought stakes while 61 increased positions. They now own 11.61 million shares or 5.96% less from 12.35 million shares in 2016Q1.
Daruma Capital Management Llc holds 2.94% of its portfolio in Analogic Corporation for 567,408 shares. Hillcrest Asset Management Llc owns 97,014 shares or 1.94% of their US portfolio. Moreover, Tributary Capital Management Llc has 1.28% invested in the company for 110,817 shares. The California-based Rice Hall James & Associates Llc has invested 1.18% in the stock. Snyder Capital Management L P, a California-based fund reported 211,966 shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.